Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Interstitial lung disease (Leflunomide - Respiratory disease indications)

Records returned : 4 (on 14 Mar 2026 at 11:10:04). Return to search results for ' Interstitial lung disease '.

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Status :
Amber
Formulations :
  • Tablets
Restrictions / Comments:

Important

Click on drug name for specific shared care document.

General principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

 

 
Links :
Off Label
SPC
Status :
Amber
Formulations :
  • Oral suspension
  • Tablets
Restrictions / Comments:

Important

Click on drug name for specific shared care document.

General principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

 

 
Links :
Off Label
SPC
Status :
Amber
Formulations :
  • Injection
  • Tablets
Restrictions / Comments:

Important

WEEKLY dosing. Only 2.5mg tablets to be prescribed. DO NOT prescribe or supply 10mg tablets

Click on drug name for specific shared care document.

General principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

 

 
Links :
Off Label
SPC
Status :
Amber
Formulations :
  • Capsules
  • Oral suspension
  • Tablets
Restrictions / Comments:

Important

Prescribe generically (except in transplant indications)

Click on drug name for specific shared care document.

General principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

 

 
Links :
Off Label
SPC